XL-protein Signs Licensing Agreement with MSD Animal Health to Develop Biopharmaceuticals using its PASylation® Technology
FREISING, GERMANY, February 12, 2015 – XL-protein GmbH, Germany,…
XL-protein and YEDA sign business collaboration agreement to commercialize PASylated interferon superagonist
FREISING, GERMANY & REHOVOT, ISRAEL, October 21, 2014 –
Yeda…
XL-protein announces publication of key scientific data on its PASylation® technology
FREISING, GERMANY, August 30, 2013 – XL-protein GmbH announced…